
AI company Dust is pioneering a shift from single-player to multiplayer AI in workplaces, where AI agents collaborate across departments. This approach allows for shared workflows and learning, enhancing team productivity rather than just individual efficiency. However, it necessitates new governance models to manage data access and prevent unauthorized AI use. As this trend grows, companies will need to focus on managing an agent workforce effectively, with roles like AI operators becoming crucial.
Read originalEarlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
Fractile has secured a massive £540 million Series C, signaling intense capital competition for the UK’s leading AI chip designer. This valuation underscores the strategic pivot toward domestic semiconductor sovereignty in Europe, moving beyond software to hard infrastructure. The funding validates Fractile’s approach to custom silicon for large language models, positioning it as a critical alternative to NVIDIA’s dominance in the European market. Investors are betting heavily on the premise that sovereign AI requires sovereign hardware.
Lev Selector · April 3, 2026 · Background
The AI Daily Brief · April 26, 2026 · Background
The AI Daily Brief · May 26, 2026 · Related
Hugging Face Blog · June 1, 2026 · Related
MIT Technology Review AI · June 9, 2026 · Related
OpenAI · June 25, 2026 · Related
MIT Technology Review AI · June 29, 2026 · Related
Sifted · July 1, 2026 · Background
OpenAI · July 27, 2026 · Related
Cole Medin · September 17, 2026 · Background
AI News · September 18, 2026 · Background
Lev Selector · October 2, 2026 · Background
TechCrunch AI · October 19, 2026 · Related
Deeptech startup MuRay has secured €7.1 million to deploy AI-driven computer vision for inspecting rocket engines. This funding targets the development of systems that can see inside complex combustion chambers, a task traditionally reliant on manual human inspection or invasive physical probes. By automating this critical quality control step, MuRay aims to reduce downtime and improve safety in aerospace manufacturing. The deal highlights growing investor interest in specialized industrial AI applications beyond consumer tech.
Exin Therapeutics has demonstrated an AI agent physically controlling a robotic arm to inject drugs into a live mouse's brain. The experiment reveals a critical divergence in model behavior: Anthropic’s Claude Opus refused the procedure due to safety concerns, while Sonnet proceeded. This suggests that as agents gain direct access to physical lab equipment, their alignment and refusal mechanisms become operational realities rather than theoretical safeguards. It marks a shift from AI merely analyzing data to actively manipulating biological systems under human supervision. The team initially tested Claude Opus 5.5, but it halted the injection, citing potential harm. Switching to Claude Sonnet 5 allowed the procedure to complete, though with delays caused by coordinate system glitches. A secondary Opus agent had to fix code errors without knowing a live surgery was underway. Human oversight remains essential as researchers test more complex tasks like craniotomies.